vs
Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and STONERIDGE INC (SRI). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $205.2M, roughly 1.9× STONERIDGE INC). On growth, P3 Health Partners Inc. posted the faster year-over-year revenue change (3.8% vs -6.0%). Over the past eight quarters, P3 Health Partners Inc.'s revenue compounded faster (-0.5% CAGR vs -7.4%).
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
Stoneridge Inc is a global designer and manufacturer of advanced electrical and electronic components, integrated systems, and sensor solutions. It serves automotive, commercial vehicle, off-highway, and aerospace sectors, delivering products that boost vehicle safety, efficiency, connectivity, and environmental performance across key global markets.
PIII vs SRI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $384.8M | $205.2M |
| Net Profit | $-75.5M | — |
| Gross Margin | — | 16.2% |
| Operating Margin | -40.0% | -14.4% |
| Net Margin | -19.6% | — |
| Revenue YoY | 3.8% | -6.0% |
| Net Profit YoY | -28.8% | — |
| EPS (diluted) | $-23.08 | $-2.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $384.8M | $205.2M | ||
| Q3 25 | $345.3M | $210.3M | ||
| Q2 25 | $355.8M | $228.0M | ||
| Q1 25 | $373.2M | $217.9M | ||
| Q4 24 | $370.7M | $218.2M | ||
| Q3 24 | $362.1M | $213.8M | ||
| Q2 24 | $379.2M | $237.1M | ||
| Q1 24 | $388.5M | $239.2M |
| Q4 25 | $-75.5M | — | ||
| Q3 25 | $-31.6M | $-9.4M | ||
| Q2 25 | $-20.4M | $-9.4M | ||
| Q1 25 | $-20.5M | $-7.2M | ||
| Q4 24 | $-58.6M | — | ||
| Q3 24 | $-46.5M | $-7.1M | ||
| Q2 24 | $-12.0M | $2.8M | ||
| Q1 24 | $-18.7M | $-6.1M |
| Q4 25 | — | 16.2% | ||
| Q3 25 | — | 20.3% | ||
| Q2 25 | — | 21.5% | ||
| Q1 25 | — | 21.2% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | — | 22.7% | ||
| Q1 24 | — | 20.2% |
| Q4 25 | -40.0% | -14.4% | ||
| Q3 25 | -12.8% | -1.6% | ||
| Q2 25 | -9.6% | -1.1% | ||
| Q1 25 | -10.2% | -1.5% | ||
| Q4 24 | -37.4% | -2.0% | ||
| Q3 24 | -29.5% | 0.1% | ||
| Q2 24 | -8.3% | 1.4% | ||
| Q1 24 | -11.3% | 0.1% |
| Q4 25 | -19.6% | — | ||
| Q3 25 | -9.1% | -4.5% | ||
| Q2 25 | -5.7% | -4.1% | ||
| Q1 25 | -5.5% | -3.3% | ||
| Q4 24 | -15.8% | — | ||
| Q3 24 | -12.8% | -3.3% | ||
| Q2 24 | -3.2% | 1.2% | ||
| Q1 24 | -4.8% | -2.6% |
| Q4 25 | $-23.08 | $-2.76 | ||
| Q3 25 | $-9.67 | $-0.34 | ||
| Q2 25 | $-6.23 | $-0.34 | ||
| Q1 25 | $-6.28 | $-0.26 | ||
| Q4 24 | $-23.13 | $-0.22 | ||
| Q3 24 | $-15.70 | $-0.26 | ||
| Q2 24 | $-7.37 | $0.10 | ||
| Q1 24 | $-7.86 | $-0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.0M | $66.3M |
| Total DebtLower is stronger | $228.4M | $180.9M |
| Stockholders' EquityBook value | $-155.2M | $179.8M |
| Total Assets | $656.6M | $551.2M |
| Debt / EquityLower = less leverage | — | 1.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.0M | $66.3M | ||
| Q3 25 | $37.7M | $54.0M | ||
| Q2 25 | $38.6M | $49.8M | ||
| Q1 25 | $40.1M | $79.1M | ||
| Q4 24 | $38.8M | $71.8M | ||
| Q3 24 | $63.0M | $54.1M | ||
| Q2 24 | $73.1M | $42.1M | ||
| Q1 24 | $27.3M | $48.4M |
| Q4 25 | $228.4M | $180.9M | ||
| Q3 25 | $252.8M | — | ||
| Q2 25 | $182.0M | — | ||
| Q1 25 | $171.1M | — | ||
| Q4 24 | $108.9M | $201.6M | ||
| Q3 24 | $133.2M | — | ||
| Q2 24 | $133.1M | — | ||
| Q1 24 | $118.1M | — |
| Q4 25 | $-155.2M | $179.8M | ||
| Q3 25 | $-18.7M | $251.2M | ||
| Q2 25 | $44.5M | $260.5M | ||
| Q1 25 | $63.3M | $253.1M | ||
| Q4 24 | $75.9M | $245.3M | ||
| Q3 24 | $120.5M | $271.4M | ||
| Q2 24 | $166.8M | $270.5M | ||
| Q1 24 | $146.6M | $277.3M |
| Q4 25 | $656.6M | $551.2M | ||
| Q3 25 | $683.6M | $632.1M | ||
| Q2 25 | $731.6M | $639.4M | ||
| Q1 25 | $783.9M | $657.4M | ||
| Q4 24 | $783.4M | $621.6M | ||
| Q3 24 | $833.3M | $662.5M | ||
| Q2 24 | $892.8M | $666.7M | ||
| Q1 24 | $855.9M | $675.4M |
| Q4 25 | — | 1.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.09× | — | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | 1.43× | 0.82× | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.80× | — | ||
| Q1 24 | 0.81× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.7M | $8.8M |
| Free Cash FlowOCF − Capex | — | $2.6M |
| FCF MarginFCF / Revenue | — | 1.3% |
| Capex IntensityCapex / Revenue | — | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $12.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.7M | $8.8M | ||
| Q3 25 | $-15.4M | $3.6M | ||
| Q2 25 | $-16.6M | $10.7M | ||
| Q1 25 | $-33.5M | $10.9M | ||
| Q4 24 | $-57.2M | $19.2M | ||
| Q3 24 | $-22.6M | $10.8M | ||
| Q2 24 | $-10.2M | $8.7M | ||
| Q1 24 | $-20.0M | $9.1M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $-2.7M | ||
| Q2 25 | — | $7.4M | ||
| Q1 25 | — | $4.8M | ||
| Q4 24 | — | $14.0M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | — | $3.3M |
| Q4 25 | — | 1.3% | ||
| Q3 25 | — | -1.3% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 6.4% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | — | 3.0% | ||
| Q3 25 | — | 3.0% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | 0.0% | 2.4% | ||
| Q3 24 | 0.0% | 2.9% | ||
| Q2 24 | 0.0% | 3.0% | ||
| Q1 24 | 0.0% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.11× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
SRI
| Control Devices | $51.7M | 25% |
| Electronics | $38.0M | 19% |
| EE | $34.2M | 17% |
| SE | $28.6M | 14% |
| NL | $24.5M | 12% |
| Stoneridge Brazil | $14.1M | 7% |
| Asia Pacific | $13.1M | 6% |
